Holoxan with uromitexan 2gm injection is an anticancer and cytoprotective drug belonging to the category of alkylating agents and hemorrhagic cystitis inhibitors, containing the active ingredient Ifosfamide and Mesna. These drugs are indicated for the treatment of bladder inflammation and cancers in the soft tissues, germ cells, pancreas, and cervix. Mesna mainly protects against some of the harmful effects of certain chemotherapy medications. 

If you had an allergic reaction to this drug or any of its components, it should not be used. This medicine may cause severe bone marrow suppression which results in low white blood cell count or low platelet count due to chemotherapy or radiation therapy. You should wait for three months before starting the treatment with this drug if you have received a live virus vaccine such as measles, mumps, rubella, or chickenpox. It is advised to use this drug with caution in severe kidney or liver-diseased individuals. Talk to your doctor if you take any other medications or before using over-the-counter medicines or herbal products. Your doctor will evaluate the risk of interaction with this medication.

Hemorrhagic cystitis (bladder inflammation)

Soft tissue cancer

Germ cell cancer

Pancreatic cancer

Cervical cancer

These two combinations together work by damaging the DNA in cancer cells, which leads to cell death and slows the growth and spread of cancer. Mostly, this involves the formation of reactive metabolites in the liver, which are then transported to cancer cells in the body. These metabolites react with the DNA in the cancer cells, causing cross-links and breaks in the DNA strands. This interferes with the replication and transcription of DNA, leading to cell death.

It will be given to you by a doctor or nurse in a hospital or clinic setting trained in cancer chemotherapy. Holoxan with uromitexan 2gm injection is given as an intravenous infusion drip (into your vein). Do not self-administer the injection. Your doctor will decide the dose and duration of the treatment based on your disease severity, body weight, and other factors.

Immune system suppression

Low levels of RBC, WBC, and platelets in the blood

Bone marrow suppression

Nerve toxicity

Urinary problems

Lung problems

Kidney problem

Rash

Hypersensitivity reactions

Hair loss

Fever

Phlebitis

Liver toxicity

Infections

Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Holoxan with uromitexan 2gm injection and reduce effectiveness by causing undesirable side effects. 

Store Holoxan with uromitexan 2gm injection in a refrigerator (20°C to 25°C).

Do not freeze.

Keep it out of reach from children.

This injection may cause severe birth defects if taken during pregnancy. Female patients with reproductive potential should use effective contraception during the treatment. Male patients with female partners with reproductive potential should use effective birth control methods during the treatment and for at least 5 months after their last dose. Do not breastfeed during treatment with this injection. Your doctor may advise you to take certain tests to check for the effectiveness of the therapy. Holoxan with uromitexan 2gm injection may cause dizziness, drowsiness, or blurred vision, so it is important to avoid driving. It's important to avoid consuming grapefruit or grapefruit juice while taking this injection because this can lead to increased levels of the drug in your body and a higher risk of side effects. If you miss a dose of this drug and it is close to the time for your next scheduled dose, you should skip the missed dose and continue with your regular dosing schedule. It is not recommended to take a double dose to make up for a missed one.